Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NVCR NovoCure Limited daily Stock Chart
NVCR [NASD]
NovoCure Limited
Healthcare | Medical Appliances & Equipment | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.44 Insider Own2.10% Shs Outstand94.79M Perf Week8.37%
Market Cap8.88B Forward P/E218.46 EPS next Y0.43 Insider Trans-41.48% Shs Float80.42M Perf Month31.96%
Income-40.70M PEG- EPS next Q-0.04 Inst Own74.50% Short Float6.57% Perf Quarter86.03%
Sales294.50M P/S30.17 EPS this Y36.50% Inst Trans2.85% Short Ratio6.77 Perf Half Y76.20%
Book/sh1.65 P/B56.80 EPS next Y326.30% ROA-11.40% Target Price85.00 Perf Year156.42%
Cash/sh3.00 P/C31.21 EPS next 5Y- ROE-31.80% 52W Range26.02 - 94.55 Perf YTD179.93%
Dividend- P/FCF368.62 EPS past 5Y5.90% ROI-19.60% 52W High0.40% Beta2.29
Dividend %- Quick Ratio4.70 Sales past 5Y88.70% Gross Margin71.80% 52W Low264.83% ATR3.49
Employees598 Current Ratio5.00 Sales Q/Q41.00% Oper. Margin-6.40% RSI (14)76.77 Volatility4.44% 4.57%
OptionableYes Debt/Eq0.94 EPS Q/Q92.20% Profit Margin-13.80% Rel Volume2.29 Prev Close93.72
ShortableYes LT Debt/Eq0.94 EarningsJul 25 BMO Payout- Avg Volume779.91K Price94.93
Recom2.30 SMA2014.78% SMA5035.02% SMA20088.33% Volume680,319 Change1.29%
Jul-29-19Upgrade SunTrust Hold → Buy
Jul-26-19Downgrade Wedbush Outperform → Neutral $57 → $80
Jul-26-19Downgrade JP Morgan Overweight → Neutral $61 → $79
Mar-20-19Initiated SunTrust Hold
Nov-02-18Downgrade Wells Fargo Outperform → Market Perform
Jul-16-18Initiated Evercore ISI Outperform $46
Apr-18-18Reiterated Mizuho Buy $28 → $32
Feb-23-18Reiterated Mizuho Buy $25 → $28
May-24-17Upgrade Wells Fargo Market Perform → Outperform
Jul-29-16Reiterated Wedbush Outperform $30 → $20
Jan-19-16Initiated Barclays Underweight $16
Dec-02-15Initiated Deutsche Bank Hold $28
Oct-27-15Initiated Wedbush Outperform
Oct-27-15Initiated JP Morgan Overweight
Oct-27-15Initiated JMP Securities Mkt Outperform $43
Aug-14-19 05:38AM  Novocure's Charts Are as Bullish As They Get, So Here's My Strategy TheStreet.com
Aug-13-19 07:01AM  Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? Zacks
Aug-12-19 07:30AM  China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China Business Wire
Aug-07-19 11:17AM  Jim Cramer Weighs In On Funko, Citigroup And More Benzinga
10:26AM  NovoCure Looks Due for a Technical Correction TheStreet.com
Aug-06-19 09:01AM  Novocure to Participate in Three Upcoming Investor Conferences Business Wire
Aug-04-19 07:00PM  Why NovoCure Stock Soared 32% in July Motley Fool
Jul-31-19 01:13AM  NovoCure Limited (NVCR) Q2 2019 Earnings Call Transcript Motley Fool
Jul-30-19 12:32AM  Edited Transcript of NVCR earnings conference call or presentation 25-Jul-19 12:00pm GMT Thomson Reuters StreetEvents
Jul-26-19 08:57AM  NovoCure Limited (NVCR) Shares March Higher, Can It Continue? Zacks
Jul-25-19 02:52PM  Why NovoCure Stock Is Surging Today Motley Fool +8.58%
01:59PM  NovoCure Nears Profitability as Revenue Continues to Soar Motley Fool
07:30AM  NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:00AM  Novocure Reports Second Quarter 2019 Financial Results and Provides Company Update Business Wire
Jul-24-19 07:54AM  Are Investors Undervaluing NovoCure Limited (NASDAQ:NVCR) By 43%? Simply Wall St.
Jul-22-19 10:11AM  Can NovoCure's (NVCR) Steady Optune Business Aid Q2 Earnings? Zacks
07:30AM  Novocure Announces 10 Oral Presentations and a Special Session on Tumor Treating Fields at the 41st International Engineering in Medicine and Biology Conference Business Wire
Jul-18-19 07:11PM  CMS Establishes 2019 Monthly Fee Schedule Amount for Optune® Business Wire
10:33AM  NovoCure (NVCR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
06:57AM  Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma Business Wire
Jul-05-19 03:32PM  Novocure Stock Gave Quick Swing Trading Profit Investor's Business Daily
Jul-03-19 08:21AM  Why NovoCure Stock Jumped 19% in June Motley Fool
Jul-02-19 07:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $11.7 million of Shares GuruFocus.com
07:30AM  Novocure to Report Second Quarter 2019 Financial Results Business Wire
Jun-29-19 06:00AM  3 Cancer-Treatment Stocks to Buy Motley Fool
Jun-28-19 09:00AM  NovoCure (NVCR) Jumps: Stock Rises 7.1% Zacks
Jun-26-19 07:30AM  German Institute for Quality and Efficiency in Healthcare Publishes Rapid Report Noting Optunes Survival Benefit for Patients with Newly Diagnosed Glioblastoma Business Wire
Jun-24-19 08:22AM  What does NovoCure Limited's (NASDAQ:NVCR) Balance Sheet Tell Us About Its Future? Simply Wall St.
Jun-19-19 07:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $11.3 million of Shares GuruFocus.com
Jun-18-19 10:44AM  Novocure Could Climb Even Further; Here's Where to Buy TheStreet.com
Jun-14-19 09:08AM  Hedge Funds Have Never Been This Bullish On NovoCure Limited (NVCR) Insider Monkey
Jun-12-19 04:39PM  Why NovoCure's Regulatory News Is a Huge Win for Investors Motley Fool
03:13PM  Is NovoCure Limited's (NASDAQ:NVCR) CEO Overpaid Relative To Its Peers? Simply Wall St.
Jun-07-19 08:34AM  You Need This IPO On Your Radar Motley Fool
Jun-06-19 07:50AM  Why NovoCure Stock Jumped 20.5% in May Motley Fool
Jun-03-19 07:45AM  3 Fast-Growing Healthcare Stocks to Buy If the Market Crashes Motley Fool
May-24-19 07:44AM  The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice Benzinga +7.30%
07:30AM  Novocure to Participate in the Jefferies 2019 Global Healthcare Conference Business Wire
May-23-19 04:05PM  FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma Business Wire
May-13-19 03:00AM  Insulet and Novocure Are Going Gangbusters Motley Fool
May-10-19 06:30AM  Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma Business Wire
May-08-19 04:10PM  Edited Transcript of NVCR earnings conference call or presentation 2-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-07-19 10:38AM  5 Key Takeaways From NovoCure's Big First-Quarter Motley Fool
May-03-19 12:48AM  NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript Motley Fool +9.62%
May-02-19 12:02PM  NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript Motley Fool
08:16AM  The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data Benzinga
07:30AM  NovoCure (NVCR) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:18AM  NovoCure: 1Q Earnings Snapshot Associated Press
06:00AM  Novocure Reports First Quarter 2019 Financial Results and Provides Company Update Business Wire
Apr-30-19 02:20PM  The NovoCure (NASDAQ:NVCR) Share Price Is Up 275% And Shareholders Are Boasting About It Simply Wall St.
07:30AM  Novocure Announces the International Journal of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses of Tumor Treating Fields Improved Survival of Newly Diagnosed Glioblastoma Patients Business Wire
07:01AM  Jim Cramer Weighs In On Canopy Growth, Levi, Twilio And More Benzinga
Apr-26-19 10:17AM  Did Hedge Funds Drop The Ball On NovoCure Limited (NVCR) ? Insider Monkey
Apr-25-19 10:33AM  NovoCure (NVCR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-15-19 07:30AM  Novocure Publishes 2018 Annual Report Featuring Companys Vision, Mission and Values Business Wire
Apr-10-19 02:10PM  What You Should Know About NovoCure Limited's (NASDAQ:NVCR) Financial Strength Simply Wall St.
Apr-06-19 03:45PM  Why Novocure Stock Fell More Than 10% in March Motley Fool
Apr-03-19 07:30AM  Inaugural AACR-Novocure Tumor Treating Fields Research Grant Recipients Announced at AACR Annual Meeting 2019 Business Wire
Apr-02-19 07:30AM  Novocure to Report First Quarter 2019 Financial Results Business Wire
Mar-29-19 07:50AM  Investor Expectations to Drive Momentum within Apple Hospitality REIT, Superior Energy Services, US Foods Holding, NovoCure, FTS International, and Envestnet Discovering Underlying Factors of Influence GlobeNewswire
Mar-22-19 07:30AM  Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer Business Wire -5.92%
Mar-21-19 07:30AM  Novocure Announces 48 Presentations and a Symposium Session on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2019 Business Wire
06:52AM  Novocure Chief Science Officer Eilon Kirson to retire after 7 years in the role MarketWatch
06:30AM  Novocures Chief Science Officer Retires after 17 Years of Service Business Wire
Mar-18-19 07:30AM  Novocure to Participate in Oppenheimers 29th Annual Healthcare Conference Business Wire
Mar-12-19 09:37AM  Does NovoCure Limiteds (NASDAQ:NVCR) Past Performance Indicate A Weaker Future? Simply Wall St.
Mar-08-19 08:45AM  Options Traders Expect Huge Moves in NovoCure (NVCR) Stock Zacks
Mar-04-19 11:58PM  Edited Transcript of NVCR earnings conference call or presentation 28-Feb-19 1:00pm GMT Thomson Reuters StreetEvents -5.83%
06:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $5.6 million of Shares GuruFocus.com
Feb-28-19 03:21PM  NovoCure (NVCR) Q4 2018 Earnings Conference Call Transcript Motley Fool
06:00AM  Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update Business Wire
Feb-21-19 11:49AM  3 Medical Device Companies for Your Watchlist Motley Fool
Jan-23-19 11:38AM  How Many Insiders Sold NovoCure Limited (NASDAQ:NVCR) Shares? Simply Wall St.
Jan-18-19 06:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $9 million of Shares GuruFocus.com
Jan-16-19 06:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $8.7 million of Shares GuruFocus.com
Jan-11-19 12:24PM  Tamarack Capital Managements Return, AUM, and Holdings Insider Monkey
Jan-07-19 04:05PM  Novocure Announces Fourth Quarter and Full Year 2018 Operating Statistics, Preliminary Net Revenues and Provides Company Update Business Wire
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals
Dec-24-18 09:44AM  Is NovoCure a Buy? Motley Fool
Dec-21-18 07:30AM  Novocure to Participate in the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-17-18 02:20PM  What Kind Of Shareholder Owns Most NovoCure Limited (NASDAQ:NVCR) Stock? Simply Wall St.
07:30AM  Novocure and the AACR Announce Four Inaugural Research Grants to Promote and Support Innovative Research on Tumor Treating Fields Business Wire
Dec-16-18 09:10AM  Is NovoCure Limited (NVCR) A Good Stock To Buy? Insider Monkey
Dec-12-18 11:49AM  3 Top Medical Device Stocks to Buy Now Motley Fool
Dec-07-18 07:55AM  Recent Analysis Shows Moody's, Hershey, NovoCure, Mohawk Industries, La-Z-Boy, and Lockheed Martin Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Dec-06-18 07:30AM  Sub-Group Analysis of Novocures EF-14 Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Published in Journal of Neuro-Oncology Demonstrating More Time on Optune® Predicted Increased Survival Business Wire
Nov-14-18 07:30AM  Zai Lab and Novocure Awarded Deal of the Year GlobeNewswire
07:30AM  Novocure and Zai Lab Awarded Deal of the Year at 5th Annual BioCentury China Healthcare Summit in Shanghai, China Business Wire
Nov-13-18 08:01PM  3 Top Healthcare Stocks to Buy in November Motley Fool
08:24AM  Novocure Announces More than 70 Presentations on Tumor Treating Fields at 23rd Annual Meeting of the Society for Neuro-Oncology Business Wire
Nov-07-18 04:00PM  Novocure and Zai Lab to Host Investor Event Business Wire +8.33%
12:25PM  NovoCure Limited (NASDAQ:NVCR): Is Breakeven Near? Simply Wall St.
11:22AM  Here's Why NovoCure Fell 36.8% in October Motley Fool
Oct-30-18 02:04PM  Edited Transcript of NVCR earnings conference call or presentation 25-Oct-18 12:00pm GMT Thomson Reuters StreetEvents
07:30AM  New Research Coverage Highlights HomeStreet, Cousins Properties, Carbo Ceramics, Cowen Group, CTS, and NovoCure Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-25-18 03:11PM  Here's Why Novocure Is Tumbling Today Motley Fool -18.98%
09:05AM  NovoCure (NVCR) Reports Q3 Loss, Misses Revenue Estimates Zacks
06:00AM  Novocure Reports Third Quarter 2018 Financial Results and Provides Company Update Business Wire
Oct-24-18 04:00PM  Novocure Founder Professor Yoram Palti and Director Louis J. Lavigne, Jr. Retire from Board of Directors Business Wire
Oct-23-18 05:57PM  Higher Delivered Dose of Tumor Treating Fields to Tumor Bed Associated with Improved Overall Survival in Newly Diagnosed Glioblastoma Business Wire
Markets a wearable electric field device for treating glioblastoma brain cancer.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEUNG GABRIELDirectorAug 12Option Exercise3.445,00017,20074,504Aug 14 04:18 PM
LEUNG GABRIELDirectorAug 12Sale86.455,000432,25069,504Aug 14 04:18 PM
Shah PriteshChief Commercial OfficerAug 02Sale85.231,813154,52276,976Aug 06 04:43 PM
Shah PriteshChief Commercial OfficerAug 01Sale83.201,905158,50278,789Aug 02 04:13 PM
Shah PriteshChief Commercial OfficerJul 31Option Exercise54.758,833483,61982,091Aug 02 04:13 PM
Shah PriteshChief Commercial OfficerJul 31Sale82.925,115424,13676,976Aug 02 04:13 PM
Shah PriteshChief Commercial OfficerJul 26Option Exercise19.2512,500240,62589,476Jul 30 03:57 PM
Shah PriteshChief Commercial OfficerJul 26Sale77.9412,500974,20876,976Jul 30 03:57 PM
Shah PriteshChief Commercial OfficerJul 18Option Exercise27.607,500207,00084,476Jul 22 10:47 AM
Shah PriteshChief Commercial OfficerJul 18Sale70.007,500525,00076,976Jul 22 10:47 AM
LEUNG GABRIELDirectorJul 10Option Exercise3.445,00017,20074,504Jul 12 04:04 PM
LEUNG GABRIELDirectorJul 10Sale64.835,000324,15569,504Jul 12 04:04 PM
Danziger AsafChief Executive OfficerJun 28Option Exercise7.15187,5001,340,625445,811Jul 02 04:12 PM
Danziger AsafChief Executive OfficerJun 28Sale62.15187,50011,653,125258,311Jul 02 04:12 PM
Shah PriteshChief Commercial OfficerJun 27Sale60.3011,175673,85365,037Jun 28 06:55 PM
Ambrogi Michael J.Chief Operating OfficerJun 19Option Exercise22.00110,8682,439,096296,542Jun 21 04:01 PM
Danziger AsafChief Executive OfficerJun 19Option Exercise11.4625,000286,500283,311Jun 21 04:03 PM
LEUNG GABRIELDirectorJun 19Option Exercise3.4425,00086,00094,504Jun 21 04:05 PM
Shah PriteshChief Commercial OfficerJun 19Option Exercise11.8512,500148,12588,712Jun 21 04:06 PM
Ambrogi Michael J.Chief Operating OfficerJun 19Sale60.00110,8686,652,080185,674Jun 21 04:01 PM
Danziger AsafChief Executive OfficerJun 19Sale61.4625,0001,536,500258,311Jun 21 04:03 PM
LEUNG GABRIELDirectorJun 19Sale60.0225,0001,500,50069,504Jun 21 04:05 PM
Shah PriteshChief Commercial OfficerJun 19Sale60.0012,500750,00076,212Jun 21 04:06 PM
Danziger AsafChief Executive OfficerJun 18Option Exercise14.37190,3382,735,157448,649Jun 19 04:16 PM
Danziger AsafChief Executive OfficerJun 18Sale59.37190,33811,300,367258,311Jun 19 04:16 PM
Danziger AsafChief Executive OfficerJun 12Option Exercise14.3730,436437,365288,747Jun 13 04:16 PM
Danziger AsafChief Executive OfficerJun 12Sale55.3930,4361,685,965258,311Jun 13 04:16 PM
Danziger AsafChief Executive OfficerJun 11Option Exercise14.3716,835241,919275,146Jun 13 04:16 PM
Danziger AsafChief Executive OfficerJun 11Sale54.7516,835921,651258,311Jun 13 04:16 PM
LEUNG GABRIELDirectorJun 10Option Exercise3.445,00017,20074,504Jun 12 04:12 PM
LEUNG GABRIELDirectorJun 10Sale55.055,000275,26669,504Jun 12 04:12 PM
Shah PriteshChief Commercial OfficerJun 10Sale55.051,13062,21276,212Jun 12 04:13 PM
Ambrogi Michael J.Chief Operating OfficerJun 06Option Exercise7.155,99942,893191,673Jun 10 04:13 PM
Ambrogi Michael J.Chief Operating OfficerJun 06Sale54.795,999328,661185,674Jun 10 04:13 PM
Ambrogi Michael J.Chief Operating OfficerJun 05Option Exercise7.1517,500125,125203,174Jun 06 04:10 PM
Ambrogi Michael J.Chief Operating OfficerJun 05Sale54.1417,500947,485185,674Jun 06 04:10 PM
Ambrogi Michael J.Chief Operating OfficerJun 04Option Exercise7.1517,500125,125203,174Jun 05 04:33 PM
Ambrogi Michael J.Chief Operating OfficerJun 04Sale53.1217,500929,613185,674Jun 05 04:33 PM
Ambrogi Michael J.Chief Operating OfficerJun 03Option Exercise7.1517,500125,125203,174Jun 05 04:33 PM
Ambrogi Michael J.Chief Operating OfficerJun 03Sale52.1217,500912,128185,674Jun 05 04:33 PM
DOYLE WILLIAM FExecutive ChairmanMay 30Sale53.0748,1002,552,523846,463Jun 03 04:08 PM
PHILLIPS CHARLES G IIIDirectorMay 29Option Exercise9.1695,100871,16559,504May 31 04:11 PM
DOYLE WILLIAM FExecutive ChairmanMay 29Sale53.101,900100,881894,563May 31 04:12 PM
PHILLIPS CHARLES G IIIDirectorMay 29Sale52.1795,1004,961,1989,504May 31 04:11 PM
Burkoth William T.DirectorMay 21Option Exercise48.876,145300,3066,145May 22 04:27 PM
LEUNG GABRIELDirectorMay 21Option Exercise48.876,145300,30666,145May 22 04:26 PM
VERNON W ANTHONYDirectorMay 21Option Exercise48.876,145300,306255,230May 22 04:25 PM
PHILLIPS CHARLES G IIIDirectorMay 21Option Exercise48.876,145300,3066,145May 22 04:24 PM
Madden Martin J.DirectorMay 21Option Exercise48.878,906435,2368,906May 22 04:21 PM
LEUNG GABRIELDirectorMay 10Option Exercise3.445,00017,20065,000May 14 04:08 PM
LEUNG GABRIELDirectorMay 10Sale49.795,000248,95060,000May 14 04:08 PM
DOYLE WILLIAM FExecutive ChairmanMay 09Sale47.3731,4601,490,386896,463May 10 04:13 PM
DOYLE WILLIAM FExecutive ChairmanMay 08Option Exercise47.6258,7682,798,532927,923May 09 04:20 PM
DOYLE WILLIAM FExecutive ChairmanMay 08Sale47.5232,2181,531,032869,155May 09 04:20 PM
DOYLE WILLIAM FExecutive ChairmanMay 07Option Exercise48.9258,7682,874,931901,373May 09 04:20 PM
DOYLE WILLIAM FExecutive ChairmanMay 07Sale47.6732,0981,530,112842,605May 09 04:20 PM
DOYLE WILLIAM FExecutive ChairmanMay 06Option Exercise48.8958,7682,873,168874,703May 07 04:28 PM
DOYLE WILLIAM FExecutive ChairmanMay 06Sale48.0729,0381,395,915815,935May 07 04:28 PM
DOYLE WILLIAM FExecutive ChairmanMay 03Option Exercise44.6058,7682,621,053844,973May 06 05:48 PM
DOYLE WILLIAM FExecutive ChairmanMay 03Sale45.2129,9661,354,643786,205May 06 05:48 PM
DOYLE WILLIAM FExecutive ChairmanMay 02Option Exercise43.2858,7682,543,479816,171May 06 05:48 PM
Shah PriteshChief Commercial OfficerMay 02Sale43.801,20452,72977,342May 03 04:15 PM
Shah PriteshChief Commercial OfficerMay 01Option Exercise44.072,334102,85978,546May 03 04:15 PM
LEUNG GABRIELDirectorApr 10Option Exercise3.445,00017,20065,000Apr 12 04:05 PM
LEUNG GABRIELDirectorApr 10Sale45.955,000229,75060,000Apr 12 04:05 PM
Ambrogi Michael J.Chief Operating OfficerApr 02Option Exercise14.3715,516222,965201,190Apr 03 04:25 PM
Ambrogi Michael J.Chief Operating OfficerApr 02Sale47.2415,516733,039185,674Apr 03 04:25 PM
Ambrogi Michael J.Chief Operating OfficerApr 01Option Exercise13.3134,375457,594207,549Apr 03 04:25 PM
Ambrogi Michael J.Chief Operating OfficerApr 01Sale47.3934,3751,629,014185,674Apr 03 04:25 PM
Shah PriteshChief Commercial OfficerMar 28Option Exercise6.8032,521221,29176,212Apr 01 04:15 PM
LEUNG GABRIELDirectorMar 11Option Exercise3.445,00017,20065,000Mar 12 04:56 PM
LEUNG GABRIELDirectorMar 11Sale48.315,000241,55060,000Mar 12 04:56 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerMar 05Option Exercise3.4431,234107,44597,498Mar 06 04:18 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerMar 05Sale53.4031,2341,668,02166,264Mar 06 04:18 PM
Danziger AsafChief Executive OfficerMar 04Option Exercise14.3716,268233,771250,025Mar 06 04:17 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerMar 04Option Exercise3.4458,766202,155106,264Mar 06 04:18 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerMar 04Sale54.2258,7663,186,29166,264Mar 06 04:18 PM
Danziger AsafChief Executive OfficerMar 04Sale55.8916,268909,286233,757Mar 06 04:17 PM
Shah PriteshChief Commercial OfficerMar 01Option Exercise13.7740,586558,81042,136Mar 04 04:13 PM
Danziger AsafChief Executive OfficerMar 01Option Exercise14.37100,0001,437,000333,757Mar 04 04:15 PM
LEUNG GABRIELDirectorMar 01Option Exercise3.4425,00086,00085,000Mar 04 04:14 PM
Shah PriteshChief Commercial OfficerMar 01Sale55.6340,5862,257,69725,239Mar 04 04:13 PM
Danziger AsafChief Executive OfficerMar 01Sale55.57100,0005,556,582233,757Mar 04 04:15 PM
LEUNG GABRIELDirectorMar 01Sale55.0125,0001,375,27560,000Mar 04 04:14 PM
Danziger AsafChief Executive OfficerFeb 28Option Exercise14.3790312,976234,660Mar 01 04:31 PM
Longsworth Todd ChristopherGeneral CounselFeb 28Sale53.682,368127,11436,835Mar 01 04:30 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 28Sale53.683,288176,50066,264Mar 01 04:36 PM
DOYLE WILLIAM FExecutive ChairmanFeb 28Sale53.683,097166,247918,306Mar 01 04:52 PM
Shah PriteshChief Commercial OfficerFeb 28Sale53.681,55883,63325,239Mar 01 04:32 PM
Danziger AsafChief Executive OfficerFeb 28Sale54.4090349,119233,757Mar 01 04:31 PM
Ambrogi Michael J.Chief Operating OfficerFeb 28Sale53.682,397128,671169,305Mar 01 04:35 PM
Ambrogi Michael J.Chief Operating OfficerFeb 27Option Exercise52.906,174326,605171,702Mar 01 04:35 PM
Kirson Eilon D.Chief Science OfficerFeb 27Option Exercise52.906,945367,391152,408Mar 01 04:34 PM
Danziger AsafChief Executive OfficerFeb 27Option Exercise52.909,260489,854233,757Mar 01 04:31 PM
Shah PriteshChief Commercial OfficerFeb 27Option Exercise52.903,087163,30226,797Mar 01 04:32 PM
DOYLE WILLIAM FExecutive ChairmanFeb 27Option Exercise52.909,260489,854921,403Mar 01 04:52 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 27Option Exercise52.907,717408,22969,552Mar 01 04:36 PM
Longsworth Todd ChristopherGeneral CounselFeb 27Option Exercise52.905,556293,91239,203Mar 01 04:30 PM
Shah PriteshChief Commercial OfficerFeb 25Sale53.636,377341,98623,710Feb 26 05:56 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 25Sale53.6318,6471,000,00161,835Feb 26 05:58 PM
open in yahoo | open in reuters | open in google